Premium
Overall survival of patients with triple‐class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH
Author(s) -
Cornell Robert,
Hari Parameswaran,
Tang Shijie,
Biran Noa,
Callander Natalie,
Chari Ajai,
Chhabra Saurabh,
Fiala Mark A.,
Gahvari Zhubin,
Gandhi Ujjawal,
Godby Kelly,
Gupta Ridhi,
Jagannath Sundar,
Jagosky Megan,
Kang Yubin,
Kansagra Ankit,
Kauffman Michael,
Kodali Saranya,
Kumar Shaji K.,
Lakshman Arjun,
Liedtke Michaela,
Lonial Sagar,
Ma Xiwen,
Malek Ehsan,
Mansour Joshua,
McGehee Elizabeth F.,
Neppalli Amarendra,
Paul Barry,
Richardson Paul,
Scott Emma C.,
Shacham Sharon,
Shah Jatin,
Siegel David S.,
Umyarova Elvira,
Usmani Saad Z.,
Varnado William,
Vij Ravi,
Costa Luciano
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26010
Subject(s) - dexamethasone , multiple myeloma , medicine , refractory (planetary science) , oncology , biology , astrobiology